Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates - Barron's
1. Abbott's Q4 sales of $10.97B missed estimates by $0.06B. 2. Q4 earnings of $1.34 per share narrowly beat expectations of $1.33. 3. Organic sales growth was 10.1% for Q4, indicating strong underlying performance. 4. Guidance for 2025 projects double-digit EPS growth between $5.05 and $5.25. 5. Shares dropped 2.1% to $114.40 in premarket trading.